Fatal aplastic anemia following chloramphenicol (chloromycetin) administration.

Reports of serious toxic effects following administration of chloramphenicol have been few. After the chemical structure of this antibiotic became established, the presence of a nitrobenzene radical caused some apprehension in regard to potential toxicity. 1 The early toxicity studies on animals 2 and man 3 led to the conclusion that chloramphenicol is of low toxicity. Later hematological observations on animals following administration of chloramphenicol by various routes were believed to reveal no deleterious effects that could be ascribed to the drug. Smith and co-workers 4 found that anemia developed following intramuscular administration of chloramphenicol to dogs in a dosage of 0.05 to 0.1 gm. per kilogram of body weight. No change occurred in the total or differential white blood cell count. Anemia did not follow oral administration. Gruhzit and associates, 5 using dogs, administered chloramphenicol by different routes for as long as four months in a dosage of 0.1 to

[1]  Loyd El Aplastic anemia due to chloramphenicol. , 1952 .

[2]  M. Waid,et al.  Aplasia of the bone marrow during mesantoin therapy; report of a fatal case. , 1951, Journal of the American Medical Association.

[3]  C. Spurling,et al.  Aplastic anemia complicating streptomycin treatment of pulmonary tuberculosis; report of a case, with recovery. , 1951, Journal of the American Medical Association.

[4]  C. Reiner,et al.  Fatal aplastic anemia due to streptomycin; case report and brief review of pertinent literature. , 1951, Annals of internal medicine.

[5]  W. Altemeier,et al.  Chloramphenicol (chloromycetin) and aureomycin in surgical infections. , 1951, Journal of the American Medical Association.

[6]  E. Allott,et al.  Treatment of typhoid fever with chloramphenicol. , 1950, Lancet.

[7]  R. Ritterhoff,et al.  A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. , 1950, Annals of internal medicine.

[8]  Karlson Ag,et al.  Failure of Chloromycetin in the Treatment of Tuberculosis. , 1950 .

[9]  C. Fisch,et al.  Pancytopenia due to mesantoin: report of a case. , 1950, The New England journal of medicine.

[10]  I. Greenspan,et al.  Hemopoietic changes during administration of chloramphenicol (chloromycetin). , 1950, Journal of the American Medical Association.

[11]  J. Smadel CLINICAL USE OF THE ANTIBIOTIC CHLORAMPHENICOL (CHLOROMYCETIN , 1950 .

[12]  Crooks Hm,et al.  Chemistry of chloromycetin. , 1949 .

[13]  J. Smadel Chloramphenicol (chloromycetin) in the treatment of infectious diseases , 1949 .

[14]  R. A. Fisken,et al.  CHLORAMPHENICOL (CHLOROMYCETIN), AN ANTIBIOTIC. PHARMACOLOGICAL AND PATHOLOGICAL STUDIES IN ANIMALS. , 1949, The Journal of clinical investigation.

[15]  R. Weller,et al.  Fatal pancytopenia following the use of mesantoin; report of a case. , 1949, The New England journal of medicine.

[16]  T. Crocker,et al.  Administration of Chloromycetin to Normal Human Subjects , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  C. Tedeschi,et al.  Fatal acute pancytopenia following tridione treatment. , 1948, The New England journal of medicine.

[18]  I. W. Mclean,et al.  Chloromycetin: Biological Studies , 1948, Journal of bacteriology.

[19]  E. B. Jackson,et al.  Chloromycetin, an Antibiotic With Chemotherapeutic Activity in Experimental Rickettsial and Viral Infections. , 1947, Science.

[20]  R. Custer APLASTIC ANEMIA IN SOLDIERS TREATED WITH ATABRINE (QUINACRINE) , 1946, The American journal of the medical sciences.

[21]  L. Meyer,et al.  APLASTIC ANEMIA DUE TO SULFATHIAZOLE , 1942 .

[22]  M. Wintrobe,et al.  REPORT OF A CASE OF APLASTIC ANEMIA FOLLOWING GOLD INJECTIONS IN WHICH RECOVERY OCCURRED , 1939 .